Related references
Note: Only part of the references are listed.Atherosclerosis - An immune disease - The Anitschkov Lecture 2007
Goran K. Hansson
ATHEROSCLEROSIS (2009)
Direct antiatherosclerotic effects of PPAR agonists
Karin A. M. Jandeleit-Dahm et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study
J. Koska et al.
DIABETOLOGIA (2009)
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice
Eva J. A. Van Wanrooij et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice
Vincent Braunersreuther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice
Yukinori Tamura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
T-lymphocyte infiltration in visceral adipose tissue -: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance
Ulrich Kintscher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity
Kihwa Kang et al.
CELL METABOLISM (2008)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men
Paul M. Ridker et al.
CIRCULATION (2008)
Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
Interferon-γ, a Th1 Cytokine, Regulates Fat Inflammation A Role for Adaptive Immunity in Obesity
Viviane Zorzanelli Rocha et al.
CIRCULATION RESEARCH (2008)
Toll-Like Receptor 2 Mediates Apolipoprotein CIII-Induced Monocyte Activation
Akio Kawakami et al.
CIRCULATION RESEARCH (2008)
Macrophage chemoattractant protein-1 deficiency fails to restrain macrophage infiltration into adipose tissue
Elizabeth A. Kirk et al.
DIABETES (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The multiple facets of the fat tissue
Viviane Zorzanelli Rocha et al.
THYROID (2008)
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Amy Fleischman et al.
DIABETES CARE (2008)
Adiposity and cardiovascular disorders - Disturbance of the regulatory system consisting of humoral and neuronal signals
Hideki Katagiri et al.
CIRCULATION RESEARCH (2007)
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Justin I. Odegaard et al.
NATURE (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
C-Reactive protein and the prediction of cardiovascular events among those at intermediate risk - Moving an inflammatory hypothesis toward consensus
Paul M. Ridker
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
T-cell accumulation and regulated on activation, normal T cell expressed and secreted Upregulation in adipose tissue in obesity
Huaizhu Wu et al.
CIRCULATION (2007)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score
Paul M. Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice
Vincent Braunersreuther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets
Jonathan D. Brown et al.
CIRCULATION (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue
Karen E. Inouye et al.
DIABETES (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women
Brendan M. Everett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
TLR4 links innate immunity and fatty acid-induced insulin resistance
Hang Shi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis
Murray C. H. Clarke et al.
NATURE MEDICINE (2006)
An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy
Daniel Steinberg
JOURNAL OF LIPID RESEARCH (2006)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
Hajime Kanda et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells
Eric A. Heller et al.
CIRCULATION (2006)
Adiponectin: a key adipocytokine in metabolic syndrome
Y Okamoto et al.
CLINICAL SCIENCE (2006)
Natural regulatory T cells control the development of atherosclerosis in mice
H Ait-Oufella et al.
NATURE MEDICINE (2006)
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Chemokines as potential therapeutic targets in atherosclerosis
YA Sheikine et al.
CURRENT DRUG TARGETS (2006)
An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it - almost
D Steinberg
JOURNAL OF LIPID RESEARCH (2006)
Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans
S Cinti et al.
JOURNAL OF LIPID RESEARCH (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
An interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia
D Steinberg
JOURNAL OF LIPID RESEARCH (2005)
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
S Ogawa et al.
CELL (2005)
C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men:: a population-based cohort study
DE Laaksonen et al.
EUROPEAN HEART JOURNAL (2005)
C-reactive protein and the 10-year incidence of coronary heart disease in older men and women - The cardiovascular health study
M Cushman et al.
CIRCULATION (2005)
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control -: Results from the pioneer study
A Pfützner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Adipose tissue, inflammation, and cardiovascular disease
AH Berg et al.
CIRCULATION RESEARCH (2005)
Azithromycin for the secondary prevention of coronary events
JT Grayston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A potential decline in life expectancy in the United States in the 21st century
SJ Olshansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans
D Steinberg
JOURNAL OF LIPID RESEARCH (2005)
Adiponectin: action, regulation and association to insulin sensitivity
AS Lihn et al.
OBESITY REVIEWS (2005)
IKK-β links inflammation to obesity-induced insulin resistance
MC Arkan et al.
NATURE MEDICINE (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
UB Pajvani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
C-reactive protein modulates risk prediction based on the Framingham score -: Implications for future risk assessment:: Results from a large cohort study in southern Germany
W Koenig et al.
CIRCULATION (2004)
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
CM Ballantyne et al.
CIRCULATION (2004)
Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice
NR Veillard et al.
CIRCULATION RESEARCH (2004)
An interpretive history of the cholesterol controversy: part I
D Steinberg
JOURNAL OF LIPID RESEARCH (2004)
Inflammatory markers and the risk of coronary heart disease in men and women.
JK Pai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and β
AC Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients
JS Sidhu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Azithromycin for the secondary prevention of coronary heart disease events - The WIZARD study: A randomized controlled trial
CM O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice
P Davenport et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse
C Buono et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis
P Lesnik et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice
S Inoue et al.
CIRCULATION (2002)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Progression of atheroma - A struggle between death and procreation
YH Geng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice
VL King et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice
Z Mallat et al.
CIRCULATION RESEARCH (2001)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Peroxisome proliferator-activate inhibit development of atherosclerosis in LDL receptor-deficient mice
AC Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
